Objective: Different randomized trials have shown an excess of minor strokes in patients assigned to carotid artery stenting (CAS) compared with those assigned to carotid endarterectomy (CEA), with no difference in rates of disabling stroke or death between the two approaches. We sought to assess the severity and impact of perioperative stroke after CEA and CAS using a real-world national data set.
Methods: A retrospective analysis of 22,116 CEA and 690 CAS cases in the targeted American College of Surgeons National Surgical Quality Improvement Program (2011 Program ( -2016 data set was performed. The severity of stroke was categorized according to postoperative Rankin score to minor stroke (with no significant or slight disability, moderate disability, severe disability, and fatal stroke. Multivariate logistic regression and coarsened exact matching were performed on the basis of age, sex, race, symptomatic status, comorbidity (diabetes, chronic obstructive pulmonary disease, congestive heart failure, hypertension, chronic kidney disease, bleeding disorders), contralateral stenosis, smoking history, and the use of antiplatelets and beta blockers.
Results: The overall rate of postoperative stroke was 2.2% (CAS, 3.6%; CEA, 2.2%; P ¼ .01). On multivariate analysis, CAS was associated with 82% increased odds of 30-day stroke compared with CEA (odds ratio, 1.82; 95% confidence interval, 1.11-3.01; P ¼ .02). Around 67% of strokes occurred before the patient's discharge from the hospital, mostly within the first postoperative day (median [interquartile range]: CAS, 1 [0-1.5] days; CEA, 1 [0-4] days; P ¼ .17). Minor strokes occurred in 46.5% of patients, moderate in 18.6%, severe in 22.1%, and fatal in 12.9%. There was no difference in stroke severity between the two procedures on univariate analysis as well as after 1:1 and 1:many coarsened exact matching (Table) . Thirty-day mortality after postoperative stroke was 9.8% and was not different between CAS and CEA (16.0% vs 9.5%; P ¼ .29). Patients with more severe strokes had longer length of stay and were more likely to be discharged to rehabilitation centers and skilled facilities rather than to home (Fig) . Moreover, there was a trend of increased target lesion revascularization within 30 days in patients with severe stroke (18.1%) compared with those with minor (6.8%), moderate (11.3%), and fatal (10.2%) strokes (P ¼ .09).
Conclusions: Contrary to findings from randomized clinical trials, this study shows no significant difference in the severity of stroke after CEA vs CAS, despite an overall increased risk of stroke after CAS. A significant proportion of postoperative strokes after these procedures caused Objective: This study evaluates the risk attributable to the hemodynamic events that occur during carotid angioplasty and stenting (CAS) and the impact that preprocedural and prophylactic medications have on mitigating this risk in a large, population-based cohort of patients.
Methods: We studied all patients in the Vascular Quality Initiative who underwent CAS between January 2006 and December 2016. KaplanMeier, multivariable logistic, and Cox regression analyses were employed to evaluate the impact of periprocedural hypertension, hypotension, bradycardia, and medication use on immediate periprocedural, 30-day, and 1-year stroke.
Results: There were 13,698 CAS procedures studied. Of these, 1239 (9.1%), 1824 (13.3%), and 1333 (9.7%) patients experienced periprocedural hypertension, hypotension, and bradycardia, respectively. Immediate periprocedural stroke was 3.2% vs 2.1% vs 0.65% (P < .001), comparing patients with periprocedural hypertension vs hypotension vs normotension, and 1.4% vs 1.0% for bradycardic vs nonbradycardic patients (P ¼ .19). Periprocedural hypertension was associated with a fourfold increase in immediate periprocedural stroke (adjusted odds ratio [aOR], 3.97; 95% confidence interval [CI], 2.63-5.99; P < .001). Periprocedural hypotension and bradycardia were associated with 5.5-fold (aOR, 5.56; 95% CI, 3.24-9.52; P < .001) and 2.3-fold (aOR, 2.31; 95% CI, 1.26-4.25; P ¼ .007) increases, respectively, in immediate periprocedural stroke among patients with carotid symptoms. There was a 76% decrease in immediate periprocedural stroke risk for patients who did not experience a periprocedural hemodynamic event (aOR, 0.24; 95% CI, 0.16-0.35; P < .001). Preprocedural beta blockers and angiotensin-converting enzyme inhibitors had no significant impact on immediate periprocedural stroke. However, prophylactic use of antibradyarrhythmic agents conferred a 58% reduction in immediate periprocedural stroke among patients with carotid symptoms (aOR, 0.42; 95% CI, 0.23-0.78; P ¼ .006). The periprocedural differences in outcomes extended into the long term (Figs 1 and 2) .
Conclusions: Periprocedural hypertension in all patients and hypotension and bradycardia in patients with symptomatic carotid disease are associated with significant increase in immediate periprocedural stroke. Prophylactic administration of antibradyarrhythmic agents is associated with a decrease in the incidence of bradycardia and immediate periprocedural stroke. These results heighten the need to anticipate and promptly address these hemodynamic changes during and after CAS to further improve the risk profile of this procedure for the benefit of our patients. Objective: Transcarotid artery revascularization (TCAR) is a relatively new procedure that involves access to the proximal cervical common carotid artery (CCA), cerebral blood flow reversal as neuroprotection, and stent delivery. The purpose of this study was to describe the learning curve of TCAR.
Methods: A retrospective review of all patients sequentially undergoing TCAR at three institutions was ordered chronologically. Procedural time was defined as the time of skin incision to time of the final bandage placed on the neck wound. Flow reversal time was defined as the time when reverse flow was initiated (CCA clamped) until the reverse flow was terminated (CCA unclamped). Operative times were then grouped into bins of five and analyzed using one-way analysis of variance (ANOVA) with P < .05 considered statistically significant. Results from ANOVA led to comparison of cases 1 to 10 vs 11 to 50, accomplished using Wilcoxon signed rank test. Freedom from stroke up to 1 year for all patients who were bradycardic vs nonbradycardic in the periprocedural period.
